BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21295813)

  • 1. Fat malabsorption and increased intestinal oxalate absorption are common after Roux-en-Y gastric bypass surgery.
    Kumar R; Lieske JC; Collazo-Clavell ML; Sarr MG; Olson ER; Vrtiska TJ; Bergstralh EJ; Li X
    Surgery; 2011 May; 149(5):654-61. PubMed ID: 21295813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roux-en-Y gastric bypass is associated with early increased risk factors for development of calcium oxalate nephrolithiasis.
    Duffey BG; Pedro RN; Makhlouf A; Kriedberg C; Stessman M; Hinck B; Ikramuddin S; Kellogg T; Slusarek B; Monga M
    J Am Coll Surg; 2008 Jun; 206(6):1145-53. PubMed ID: 18501812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steatorrhea and hyperoxaluria occur after gastric bypass surgery in obese rats regardless of dietary fat or oxalate.
    Canales BK; Ellen J; Khan SR; Hatch M
    J Urol; 2013 Sep; 190(3):1102-9. PubMed ID: 23499748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass.
    Moreland AM; Santa Ana CA; Asplin JR; Kuhn JA; Holmes RP; Cole JA; Odstrcil EA; Van Dinter TG; Martinez JG; Fordtran JS
    Gastroenterology; 2017 Apr; 152(5):1055-1067.e3. PubMed ID: 28089681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass.
    Agrawal V; Liu XJ; Campfield T; Romanelli J; Enrique Silva J; Braden GL
    Surg Obes Relat Dis; 2014; 10(1):88-94. PubMed ID: 23953730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study.
    Duffey BG; Alanee S; Pedro RN; Hinck B; Kriedberg C; Ikramuddin S; Kellogg T; Stessman M; Moeding A; Monga M
    J Am Coll Surg; 2010 Jul; 211(1):8-15. PubMed ID: 20610243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperoxaluria in a Model of Mini-Gastric Bypass Surgery in Rats.
    Ormanji MS; Korkes F; Meca R; Ishiy CSRA; Finotti GHC; Ferraz RRN; Heilberg IP
    Obes Surg; 2017 Dec; 27(12):3202-3208. PubMed ID: 28550437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.
    Upala S; Jaruvongvanich V; Sanguankeo A
    Surg Obes Relat Dis; 2016; 12(8):1513-1521. PubMed ID: 27396545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxalobacter formigenes colonization normalizes oxalate excretion in a gastric bypass model of hyperoxaluria.
    Canales BK; Hatch M
    Surg Obes Relat Dis; 2017 Jul; 13(7):1152-1157. PubMed ID: 28552742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery.
    Sinha MK; Collazo-Clavell ML; Rule A; Milliner DS; Nelson W; Sarr MG; Kumar R; Lieske JC
    Kidney Int; 2007 Jul; 72(1):100-7. PubMed ID: 17377509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Calcium and Vitamin B6 Supplementation on Oxalate Excretion in a Rodent Gastric Bypass Model of Enteric Hyperoxaluria.
    Espino-Grosso P; Monsour C; Canales BK
    Urology; 2019 Feb; 124():310.e9-310.e14. PubMed ID: 30412704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanistic basis of hyperoxaluria following gastric bypass in obese rats.
    Hatch M; Canales BK
    Urolithiasis; 2016 Jun; 44(3):221-30. PubMed ID: 26584912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a probiotic to decrease enteric hyperoxaluria.
    Lieske JC; Goldfarb DS; De Simone C; Regnier C
    Kidney Int; 2005 Sep; 68(3):1244-9. PubMed ID: 16105057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enteric hyperoxaluria: role of microbiota and antibiotics.
    Liu M; Nazzal L
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):352-359. PubMed ID: 31145706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of urinary metabolic indices in severely obese adolescents after weight loss surgery.
    DeFoor WR; Asplin JR; Kollar L; Jackson E; Jenkins T; Schulte M; Inge T
    Surg Obes Relat Dis; 2016 Feb; 12(2):363-7. PubMed ID: 26077697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.
    Maalouf NM; Tondapu P; Guth ES; Livingston EH; Sakhaee K
    J Urol; 2010 Mar; 183(3):1026-30. PubMed ID: 20096421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of preoperative metabolic profiling to reduce the risk of kidney stones after bariatric surgery in patients with a history of stone formation.
    Campschroer T; Van Balken MR; Deden LN; Hazebroek EJ; De Boer H
    Surg Obes Relat Dis; 2023 Jun; 19(6):633-639. PubMed ID: 36609096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of patients with enteric hyperoxaluria.
    Asplin JR
    Urolithiasis; 2016 Feb; 44(1):33-43. PubMed ID: 26645872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to dietary oxalate after bariatric surgery.
    Froeder L; Arasaki CH; Malheiros CA; Baxmann AC; Heilberg IP
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2033-40. PubMed ID: 23024163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.